BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 6189511)

  • 1. Antenatal screening for congenital nephrosis in Finland by maternal serum alpha-fetoprotein.
    Ryynänen M; Seppälä M; Kuusela P; Rapola J; Aula P; Seppä A; Jokela V; Castren O
    Br J Obstet Gynaecol; 1983 May; 90(5):437-42. PubMed ID: 6189511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prenatal screening for congenital nephrosis in east Finland: results and impact on the birth prevalence of the disease.
    Heinonen S; Ryynänen M; Kirkinen P; Penttilä I; Syrjänen K; Seppälä M; Saarikoski S
    Prenat Diagn; 1996 Mar; 16(3):207-13. PubMed ID: 8710773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prenatal diagnosis of congenital nephrosis in 23 high-risk families.
    Aula P; Rapola J; Karjalainen O; Lindgren J; Hartikainen AL; Seppälä M
    Am J Dis Child; 1978 Oct; 132(10):984-7. PubMed ID: 82399
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Congenital nephrosis as a cause of elevated alpha-fetoprotein.
    Albright SG; Warner AA; Seeds JW; Burton BK
    Obstet Gynecol; 1990 Nov; 76(5 Pt 2):969-71. PubMed ID: 1699188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Congenital nephrosis: detection of index cases through maternal serum alpha-fetoprotein screening.
    Hogge WA; Hogge JS; Schnatterly PT; Sun CJ; Blitzer MG
    Am J Obstet Gynecol; 1992 Nov; 167(5):1330-3. PubMed ID: 1279976
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Increased AFP in maternal serum as an indication for invasive diagnosis].
    Gremm B; Sohn C; Beldermann F; Bastert G
    Zentralbl Gynakol; 1997; 119(11):560-6. PubMed ID: 9480612
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Screening for chromosomal anomalies with maternal serum alpha-fetoprotein].
    Shintaku Y; Takabayashi T; Sasaki H; Ozawa N; Shinkawa O; Hamazaki Y; Yajima A
    Nihon Sanka Fujinka Gakkai Zasshi; 1989 Feb; 41(2):185-90. PubMed ID: 2470844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic use of meternal serum alpha-fetoprotein levels.
    Cowchock FS; Jackson LG
    Obstet Gynecol; 1976 Jan; 47(1):63-8. PubMed ID: 54892
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amniotic fluid alpha-fetoprotein levels and the prenatal diagnosis of neural tube defects: a collaborative study of 2180 pregnancies in the Netherlands.
    Kleijer WJ; De Bruijn HW; Leschot NJ
    Br J Obstet Gynaecol; 1978 Jul; 85(7):512-7. PubMed ID: 79418
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amniotic-fluid alpha-fetoprotein measurement in antenatal diagnosis of anencephaly and open spina bifida in early pregnancy. Second report of the U.K. Collaborative Study on Alpha-fetoprotein in Relation to Neural-tube Defects.
    Lancet; 1979 Sep; 2(8144):651-62. PubMed ID: 90757
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Proteinuria and prenatal diagnosis of congenital nephrosis in fetal carriers of nephrin gene mutations.
    Patrakka J; Martin P; Salonen R; Kestilä M; Ruotsalainen V; Männikkö M; Ryynänen M; Rapola J; Holmberg C; Tryggvason K; Jalanko H
    Lancet; 2002 May; 359(9317):1575-7. PubMed ID: 12047969
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prenatal diagnosis of neural tube defects. IV. Maternal serum alpha-fetoprotein screening.
    Milunsky A; Alpert E; Neff RK; Frigoletto FD
    Obstet Gynecol; 1980 Jan; 55(1):60-6. PubMed ID: 6153240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased alpha-fetoprotein in amniotic fluid and maternal serum in diabetic pregnancy.
    Henriques CU; Damm P; Tabor A; Pedersen JF; Mølsted-Pedersen L
    Obstet Gynecol; 1993 Dec; 82(6):960-4. PubMed ID: 7694215
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-fetoprotein in antenatal diagnosis of congenital nephrosis.
    Kjessler B; Johansson SG; Sherman M; Gustavson KH; Hultquist G
    Lancet; 1975 Feb; 1(7904):432-3. PubMed ID: 48616
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between maternal serum and amniotic fluid alpha-fetoprotein in women undergoing early amniocentesis.
    Brumfield CG; Cloud GA; Davis RO; Finley SC; Hauth JC; Boots L
    Am J Obstet Gynecol; 1990 Sep; 163(3):903-6. PubMed ID: 1698336
    [TBL] [Abstract][Full Text] [Related]  

  • 16. False-negative A.F.P. screen for congenital nephrosis Finnish type.
    Spritz RA; Soiffer SJ; Siegel NJ; Mahoney MJ
    Lancet; 1978 Dec; 2(8102):1251. PubMed ID: 82751
    [No Abstract]   [Full Text] [Related]  

  • 17. Amniotic fluid acetylcholinesterase electrophoresis as a secondary test in the diagnosis of anencephaly and open spina bifida in early pregnancy. Report of the Collaborative acetylcholinesterase Study.
    Lancet; 1981 Aug; 2(8242):321-4. PubMed ID: 6115108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. AFP and age screening for Down syndrome.
    Wald N; Cuckle H
    Am J Med Genet; 1988 Sep; 31(1):197-209. PubMed ID: 2464930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prenatal diagnosis of congenital nephrosis.
    Rapola J
    Prog Clin Biol Res; 1985; 163B():219-20. PubMed ID: 2580313
    [No Abstract]   [Full Text] [Related]  

  • 20. Prenatal screening for congenital nephrosis.
    Ryynänen M; Castren O; Rapola J; Aula P; Seppälä M
    Lancet; 1978 Nov; 2(8097):991. PubMed ID: 82010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.